BLND vs TOST vs PGY Stock Comparison

Blend Labs, Toast and Pagaya Technologies Prices as of Oct 27, 2026 Peers: Industry group
BLND Blend Labs, Inc.
$1.17 +4.5% 1M -67.0% 1Y
Market cap
$278.29M
P/E
–
Revenue (TTM)
$129.00M
Div. yield
–
Digital Lending Technology
TOST Toast, Inc.
$31.76 +3.8% 1M -18.3% 1Y
Market cap
$18.48B
P/E
38.0x
Revenue (TTM)
$6.80B
Div. yield
–
Restaurant and Retail Software Technology
6 wins
PGY Pagaya Technologies Ltd.
$19.77 +12.2% 1M -31.9% 1Y
Market cap
$1.70B
P/E
13.5x
Revenue (TTM)
$1.39B
Div. yield
–
Digital Lending Technology
3 wins

Head to Head

9 decided of 12

Toast leads on 6 of the 12 questions below (Toast 6, Pagaya Technologies 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBLNDTOSTPGYLeader
Larger companyMarket capitalisation $278.29M $18.48B $1.70B TOST
Cheaper on earningsLower P/E, profitable companies only -12.2x 38.0x 13.5x PGY
Cheaper on forward earningsLower price / next fiscal year consensus EPS 16.7x 24.1x 11.4x PGY
Faster revenue growthRevenue growth, trailing twelve months +6.0% +23.0% +20.5% TOST
More profitableNet margin, trailing twelve months -17.7% 7.1% 9.0% PGY
Better return on capitalReturn on invested capital — — 31.5% –
Less leveragedLower net debt / EBITDA — — 0.6x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -67.0% -18.3% -31.9% TOST
Better 5-year returnAnnualised price return, 5 years -39.0%/yr -9.8%/yr -30.3%/yr TOST
Less volatileAnnualised volatility, 1 year 74.8% 48.0% 74.6% TOST
Higher overall scoreMean of the five percentile scores vs peers 65/100 70/100 69/100 TOST

Percentile Scorecard

BLNDTOSTPGY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBLNDTOSTPGY
Valuation 70 #30 of 99 50 #45 of 89 93 #8 of 99
Growth 79 #21 of 94 98 #3 of 81 91 #9 of 94
Profitability 54 #42 of 90 65 #27 of 76 85 #14 of 90
Financial Health 31 #73 of 105 72 #27 of 94 41 #62 of 105
Shareholder Returns 93 #5 of 61 66 #18 of 51 35 #40 of 61
Overall 65 70 69
  • BLND ranked among 109 companies in Fintech
  • TOST ranked among 98 companies in Vertical Software
  • PGY ranked among 109 companies in Fintech

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBLNDTOSTPGYSPY
1 month +4.5%+3.8%+12.2% -0.2%
3 months -35.0%-1.7%+19.0% +3.9%
6 months -18.2%+9.6%+46.8% +8.2%
Year to date -61.5%-10.6%-5.4% +12.9%
1 year -67.0%-18.3%-31.9% +12.3%
3 years -2.5%+101.4%+47.1% +87.4%
3 years, per year -0.8%+26.3%+13.7% +23.3%
5 years -91.6%-40.1%-83.5% +67.9%
5 years, per year -39.0%-9.8%-30.3% +10.9%

Risk

MeasureBLNDTOSTPGYSPY
Volatility, 1Y 74.8%48.0%74.6% 12.7%
Downside volatility, 1Y 83.5%52.9%77.8% 12.7%
Beta vs S&P 500, 1Y 1.631.063.17 1.00
Return / volatility, 1Y -0.90-0.38-0.43 0.97
Max drawdown, 5Y -96.5%-80.6%-98.1% -25.4%
From 52-week high -67.0%-18.6%-31.9% -1.2%
52-week high $3.55$39.02$29.01 $779.14
52-week low $0.90$22.33$10.64 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBLNDTOSTPGY
P/E now vs peer median -12.3xmedian 20.0x 37.8xmedian 40.1x 13.1xmedian 20.0x
P/S now vs peer median 2.1xmedian 2.3x 2.7xmedian 2.5x 1.2xmedian 2.3x
EV/EBITDA now vs peer median -23.2xmedian 17.5x 28.7xmedian 18.5x 4.9xmedian 17.5x
P/FCF now vs peer median 26.1xmedian 15.9x 31.8xmedian 20.1x 6.5xmedian 15.9x
P/B now vs peer median -3.7xmedian 2.0x 9.0xmedian 1.8x 2.5xmedian 2.0x
PEG now vs peer median -0.21median 1.03 0.81median 1.73 —median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBLNDTOSTPGY
Revenue $129.00M $6.80B $1.39B
Gross profit $95.88M $1.82B $603.06M
Operating income -$16.81M $431.00M $345.48M
Net income -$4.28M $486.00M $127.54M
Free cash flow $10.59M $576.00M $251.78M
R&D $34.29M $405.00M $70.60M
EPS (diluted) $-0.10 $0.82 $1.29
Cash & equivalents $23.31M $1.02B $249.26M
Total debt – – $471.87M
Shares (diluted) 239.91M 590.00M 97.25M
Enterprise value $27.30M $11.15B $676.26M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBLNDTOSTPGY
P/E -12.3x 37.8x 13.1x
P/FCF 26.1x 31.8x 6.5x
P/Operating cash flow 17.1x 28.9x 6.2x
P/S 2.1x 2.7x 1.2x
P/B -3.7x 9.0x 2.5x
P/Tangible book -3.7x 9.0x 2.6x
EV/EBITDA -23.2x 28.7x 4.9x
EV/EBIT -13.8x 38.5x 5.4x
EV/Revenue 1.8x 2.4x 1.3x
EV/FCF 21.9x 28.8x 7.4x
EV/Operating cash flow 14.3x 26.2x 7.1x
PEG (3Y EPS CAGR) -0.21 0.81 –

Growth

14 metrics
MetricBLNDTOSTPGY
Revenue growth (1Y) 6.0% 23.0% 20.5%
Revenue CAGR (3Y) -10.2% 27.1% –
Gross profit growth (1Y) 7.5% 30.5% 23.8%
Gross profit CAGR (3Y) 8.6% 38.1% –
Operating income growth (1Y) 38.6% 128.0% 118.3%
Operating income CAGR (3Y) 61.9% 47.5% –
Net income growth (1Y) 78.3% 117.0% 141.6%
Net income CAGR (3Y) 76.3% 48.7% –
EPS growth (1Y) 39.7% 122.5% 136.4%
EPS CAGR (3Y) 58.5% 46.7% –
Operating cash flow growth (1Y) 36.5% 13.8% 135.3%
Operating cash flow CAGR (3Y) 27.9% 106.7% –
Free cash flow growth (1Y) 639.8% 13.4% 160.3%
Free cash flow CAGR (3Y) 27.2% 82.9% –

Profitability

14 metrics
MetricBLNDTOSTPGY
Gross margin 74.3% 26.7% 43.4%
EBITDA margin -7.7% 8.5% 27.7%
Operating margin -13.0% 6.3% 24.9%
Pretax margin 1.4% 7.3% 7.1%
Net margin -17.7% 7.1% 9.0%
FCF margin 8.2% 8.5% 18.1%
Operating cash flow margin 12.6% 9.3% 19.0%
Return on equity – 24.1% 19.0%
Return on assets -2.8% 15.5% 7.1%
Return on invested capital – – 31.5%
Return on capital employed -15.9% 21.2% –
Asset turnover 0.8x 2.2x 0.8x
Cash conversion (OCF / net income) -3.8x 1.3x 2.1x
Stock comp / revenue 22.5% 3.4% 2.8%

Financial Health

11 metrics
MetricBLNDTOSTPGY
Debt / assets – – 27.9%
Debt / equity – – 0.7x
Net debt / EBITDA – – 0.6x
Debt / FCF – – 1.9x
Liabilities / assets 151.8% 35.7% 61.7%
Equity / assets -51.8% 64.3% 38.3%
Interest coverage – – –
Current ratio 1.6x 2.4x –
Quick ratio 1.4x 1.7x –
Cash ratio 1.0x 1.6x –
Altman Z-score -12.15 12.42 –

Shareholder Returns

7 metrics
MetricBLNDTOSTPGY
Dividend yield – – –
Net buyback yield 20.6% 2.8% -0.2%
Shareholder yield 20.6% 2.8% -0.2%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBLNDTOSTPGY
Forward P/E 16.7xFY2026 24.1xFY2026 11.4xFY2026
EPS, next fiscal year $0.07FY2026 $1.32FY2026 $1.73FY2026
EPS growth, next FY +600.0%FY2026 +34.7%FY2026 +86.0%FY2026
EPS growth, the year after -28.6% +35.6% +28.3%
Revenue, next fiscal year $125.58MFY2026 $7.84BFY2026 $1.38BFY2026
Revenue growth, next FY +1.7%FY2026 +27.5%FY2026 +6.4%FY2026
Revenue growth, the year after +6.6% +17.8% +28.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBLNDTOSTPGY
Held by institutions 63.1% 93.1% 45.0%
Institutions holding 184 774 221
Change in shares held, QoQ -4.8% +8.1% -12.0%
Institutions buying 86 427 133
Institutions selling 67 245 62
Buyers to sellers 1.28 1.74 2.15

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BLNDTOSTPGY
BLND 1.00 0.45 0.45
TOST 0.45 1.00 0.43
PGY 0.45 0.43 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BLND, TOST and PGY?

Toast (TOST) is the largest by market capitalisation: Blend Labs (BLND) $278.29M, Toast (TOST) $18.48B, Pagaya Technologies (PGY) $1.70B.

Which stock is cheaper, BLND, TOST and PGY?

Pagaya Technologies (PGY) trades on the lowest price-to-earnings ratio (Blend Labs (BLND) -12.2x, Toast (TOST) 38.0x, Pagaya Technologies (PGY) 13.5x). On next year's consensus earnings, Pagaya Technologies (PGY) is cheapest (Blend Labs (BLND) 16.7x, Toast (TOST) 24.1x, Pagaya Technologies (PGY) 11.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Toast (TOST) grew revenue fastest over the trailing twelve months: Blend Labs (BLND) +6.0%, Toast (TOST) +23.0%, Pagaya Technologies (PGY) +20.5%.

Which company is more profitable?

Pagaya Technologies (PGY) has the highest net margin (Blend Labs (BLND) -17.7%, Toast (TOST) 7.1%, Pagaya Technologies (PGY) 9.0%).

Which stock has performed better?

Over the past year Toast (TOST) returned the most: Blend Labs (BLND) -67.0%, Toast (TOST) -18.3%, Pagaya Technologies (PGY) -31.9%. Over five years, Toast (TOST) compounded fastest (Blend Labs (BLND) -39.0%/yr, Toast (TOST) -9.8%/yr, Pagaya Technologies (PGY) -30.3%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Toast (TOST) has been the steadiest (Blend Labs (BLND) 74.8%, Toast (TOST) 48.0%, Pagaya Technologies (PGY) 74.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BLND, TOST and PGY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Toast (TOST) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.